102 related articles for article (PubMed ID: 26775038)
1. Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.
Thorgeirsson T; Jordahl KM; Flavin R; Epstein MM; Fiorentino M; Andersson SO; Andren O; Rider JR; Mosquera JM; Ingoldsby H; Fall K; Tryggvadottir L; Mucci LA;
Carcinogenesis; 2016 Mar; 37(3):262-8. PubMed ID: 26775038
[TBL] [Abstract][Full Text] [Related]
2. High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.
Hammarsten P; Dahl Scherdin T; Hägglöf C; Andersson P; Wikström P; Stattin P; Egevad L; Granfors T; Bergh A
PLoS One; 2016; 11(10):e0164016. PubMed ID: 27764093
[TBL] [Abstract][Full Text] [Related]
3. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.
Kim SH; Park WS; Yun SI; Joo J; Joung JY; Seo HK; Chung J; Lee GK; Lee KH
Histopathology; 2016 Apr; 68(5):673-9. PubMed ID: 26272590
[TBL] [Abstract][Full Text] [Related]
5. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
[TBL] [Abstract][Full Text] [Related]
6. MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.
Andrén O; Fall K; Andersson SO; Rubin MA; Bismar TA; Karlsson M; Johansson JE; Mucci LA
Br J Cancer; 2007 Sep; 97(6):730-4. PubMed ID: 17726465
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
8. High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Tidehag V; Hammarsten P; Egevad L; Granfors T; Stattin P; Leanderson T; Wikström P; Josefsson A; Hägglöf C; Bergh A
Eur J Cancer; 2014 Jul; 50(10):1829-1835. PubMed ID: 24726733
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer progression and survival in BRCA2 mutation carriers.
Tryggvadóttir L; Vidarsdóttir L; Thorgeirsson T; Jonasson JG; Olafsdóttir EJ; Olafsdóttir GH; Rafnar T; Thorlacius S; Jonsson E; Eyfjord JE; Tulinius H
J Natl Cancer Inst; 2007 Jun; 99(12):929-35. PubMed ID: 17565157
[TBL] [Abstract][Full Text] [Related]
10. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers and death from prostate cancer.
Concato J; Jain D; Uchio E; Risch H; Li WW; Wells CK
Ann Intern Med; 2009 May; 150(9):595-603. PubMed ID: 19414838
[TBL] [Abstract][Full Text] [Related]
12. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy versus watchful waiting in early prostate cancer.
Bill-Axelson A; Holmberg L; Ruutu M; Garmo H; Stark JR; Busch C; Nordling S; Häggman M; Andersson SO; Bratell S; Spångberg A; Palmgren J; Steineck G; Adami HO; Johansson JE;
N Engl J Med; 2011 May; 364(18):1708-17. PubMed ID: 21542742
[TBL] [Abstract][Full Text] [Related]
14. Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer.
Hennigs JK; Minner S; Tennstedt P; Löser R; Huland H; Klose H; Graefen M; Schlomm T; Sauter G; Bokemeyer C; Honecker F
Sci Rep; 2020 Feb; 10(1):3250. PubMed ID: 32094363
[TBL] [Abstract][Full Text] [Related]
15. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Thomasson M; Wang B; Hammarsten P; Dahlman A; Persson JL; Josefsson A; Stattin P; Granfors T; Egevad L; Henriksson R; Bergh A; Hedman H
Int J Cancer; 2011 Jun; 128(12):2843-52. PubMed ID: 21128282
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Metabolism and Prostate Cancer Lethality.
Stopsack KH; Gerke TA; Sinnott JA; Penney KL; Tyekucheva S; Sesso HD; Andersson SO; Andrén O; Cerhan JR; Giovannucci EL; Mucci LA; Rider JR
Cancer Res; 2016 Aug; 76(16):4785-90. PubMed ID: 27325648
[TBL] [Abstract][Full Text] [Related]
17. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
18. Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Thorne H; Willems AJ; Niedermayr E; Hoh IM; Li J; Clouston D; Mitchell G; Fox S; Hopper JL; ; Bolton D
Cancer Prev Res (Phila); 2011 Jul; 4(7):1002-10. PubMed ID: 21733824
[TBL] [Abstract][Full Text] [Related]
19. Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
Dhillon PK; Barry M; Stampfer MJ; Perner S; Fiorentino M; Fornari A; Ma J; Fleet J; Kurth T; Rubin MA; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):595-600. PubMed ID: 19155438
[TBL] [Abstract][Full Text] [Related]
20. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Rubin MA; Bismar TA; Andrén O; Mucci L; Kim R; Shen R; Ghosh D; Wei JT; Chinnaiyan AM; Adami HO; Kantoff PW; Johansson JE
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1424-32. PubMed ID: 15941951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]